Stay up-to-date on current diabetes themes, proven therapeutic options, and knowledge resources and tools for you and your patients, and find detailed information on Novo Nordisk diabetes products.
Since the launch of its first pen needle in 1985, Novo Nordisk has been committed to enhancing injection experience
by putting technology in patient hands. NovoFine® Plus is the latest example of that commitment.
We have products for rare bleeding disorders, growth hormone-related disorders, and women’s health.
Chronic Weight Management
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
Improving Patient's Lives
For nearly a century, Novo Nordisk has focused on diabetes care and areas of unmet needs, keeping the patient at the center of everything we do.
At Novo Nordisk our leadership represents a broad, diverse array of life experiences with one very important commonality: a dedication to patient needs.
Executive Vice President,
North America Operations and President of Novo Nordisk Inc.
Corporate Vice President of Market Access
Jill Fallows Macaluso
Vice President, Chief Compliance Officer
Corporate Vice President, Human Resources
Senior Vice President, Commercial
Senior Vice President, Finance & Operations
Anne Phillips, MD
Senior Vice President, Clinical Medical and Regulatory Affairs